---
title: "tolvaptan - Polycystic Kidney, Autosomal Dominant"
sidebar: mydoc_sidebar
permalink: tolvaptanpolycystickidneyautosomaldominant.html
toc: false 
---

{% include image.html url="images/tolvaptanpolycystickidneyautosomaldominant.png" file="tolvaptanpolycystickidneyautosomaldominant.png" alt="tolvaptanpolycystickidneyautosomaldominant" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:C116664 | tolvaptan | Drug |
| UniProt:P30518 | Vasopressin V2 receptor | Protein |
| REACT:R-HSA-418555 | G alpha (s) signalling events | Pathway |
| CHEBI:17489 | 3,5-cyclic AMP | ChemicalSubstance |
| HP:0000107 | Renal cyst | PhenotypicFeature |
| GO:0008283 | cell population proliferation | BiologicalProcess |
| MESH:D016891 | Polycystic Kidney, Autosomal Dominant | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Tolvaptan | NEGATIVELY REGULATES | Vasopressin V2 Receptor |
| Vasopressin V2 Receptor | PARTICIPATES IN | G Alpha (S) Signalling Events |
| G Alpha (S) Signalling Events | INCREASES ABUNDANCE OF | 3,5-Cyclic Amp |
| 3,5-Cyclic Amp | POSITIVELY CORRELATED WITH | Cell Population Proliferation |
| 3,5-Cyclic Amp | POSITIVELY CORRELATED WITH | Renal Cyst |
| Renal Cyst | POSITIVELY CORRELATED WITH | Polycystic Kidney, Autosomal Dominant |
| Cell Population Proliferation | POSITIVELY CORRELATED WITH | Polycystic Kidney, Autosomal Dominant |
|---------|-----------|---------|

Reference: [https://go.drugbank.com/drugs/DB06212#mechanism-of-action](https://go.drugbank.com/drugs/DB06212#mechanism-of-action){:target="_blank"}